CPRX icon

Catalyst Pharmaceutical
CPRX

Overview Fund Activity

80 hedge funds and large institutions have $89.7M invested in Catalyst Pharmaceutical in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
+11
Holders Change %
+15.94%
% of All Funds
2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
21
Reduced
17
Closed
3
Calls
$83K
Puts
$130K
Net Calls
-$47K
Net Calls Change
-$1.02M

Top Buyers

1
ACA
1
Avoro Capital Advisors
New York
$11.7M
2
GCP
2
GSA Capital Partners
United Kingdom
$1.21M
3
CCM
3
Consonance Capital Management
New York
$931K
4
AQR Capital Management
4
AQR Capital Management
Connecticut
$889K
5
Morgan Stanley
5
Morgan Stanley
New York
$920K

Top Sellers

1
BC
1
Broadfin Capital
New York
$17.4M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$1.47M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$7.66M
4
Deutsche Bank
4
Deutsche Bank
Germany
$1.12M
5
BFM
5
Boothbay Fund Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
IA
76
IFP Advisors
Florida
$3K – – –
PCM
77
Prelude Capital Management
New York
$1K -$2K -540 -67%
Carson Wealth (CWM LLC)
78
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
Northwestern Mutual Wealth Management
79
Northwestern Mutual Wealth Management
Wisconsin
$1K +$1K +500 New
BFM
80
Boothbay Fund Management
New York
– -$190K -68,970 Closed
Millennium Management
81
Millennium Management
New York
– -$62K -22,564 Closed
AIM
82
Acrospire Investment Management
Illinois
– -$20K -7,268 Closed
1 2 3
4